- Home
- STG vs ATRA Comparison
STG vs ATRA Comparison
Compare STG & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STG | ATRA |
|---|---|---|
| Founded | 2003 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 46.0M | 38.9M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | STG | ATRA |
|---|---|---|
| Price | $3.44 | $4.81 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 1.6K | ★ 60.8K |
| Earning Date | 05-21-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | N/A | ★ 2.57 |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.10 | $1.94 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.21 | $3.92 |
| 52 Week High | $15.00 | $19.15 |
Technical Indicators
Market Signals| Indicator | STG | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 40.38 | 45.89 |
| Support Level | $3.22 | $4.22 |
| Resistance Level | $3.60 | $5.47 |
| Average True Range (ATR) | 0.12 | 0.38 |
| MACD | 0.04 | 0.02 |
| Stochastic Oscillator | 58.45 | 38.84 |
Price Performance
Historical ComparisonAbout STG Sunlands Technology Group
Sunlands Technology Group is a provider of online post-secondary and professional education services in China. The company offers various degree- and diploma-oriented post-secondary courses through its online platforms. In addition, it provides online professional courses and educational content to help students prepare for professional certification exams and attain professional skills. The Group has one operating segment, which is the provision of online education services.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).